Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy
Adrián Álvarez-Varela(Institute for Research in Biomedicine), Laura Novellasdemunt(Institute for Research in Biomedicine), Francisco M. Barriga(Memorial Sloan Kettering Cancer Center), Xavier Hernando‐Momblona(Institute for Research in Biomedicine), Adrià Cañellas‐Socias(Institute for Research in Biomedicine), Sara Cano-Crespo(Institute for Research in Biomedicine), Marta Sevillano(Institute for Research in Biomedicine), Carme Cortina(Institute for Research in Biomedicine), Diana Stork(Institute for Research in Biomedicine), Clara Morral(Institute for Research in Biomedicine), Gemma Turón(Institute for Research in Biomedicine), Felipe Slebe(Institute for Research in Biomedicine), Laura Jiménez-Gracia(Centre for Genomic Regulation), Ginevra Caratù(Centre for Genomic Regulation), Peter Jung(German Cancer Research Center), Giorgio Stassi(University of Palermo), Holger Heyn(Universitat Pompeu Fabra), Daniele V. F. Tauriello(Radboud University Nijmegen), Lídia Mateo(Institute for Research in Biomedicine), Sabine Tejpar(KU Leuven), Elena Sancho(Institute for Research in Biomedicine), Camille Stephan‐Otto Attolini(Institute for Research in Biomedicine), Eduard Batlle(Institute for Research in Biomedicine)
Cited by 133
Abstract
Related Papers
No related papers found
Powered by citation graph analysis